ENOV compared with IART: revenue, margins and what each company keeps, and the suppliers and customers both name

ENOVEnovis Corp

Mkt capRevenueRevenue

IARTIntegra Lifesciences Holdings Corp

Mkt capRevenueRevenue

Compare

ENOVEnovis Corp

IARTIntegra Lifesciences Holdings Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ENOV

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.8%▼−12.82%×1.08

Q1 FY26±6.8%▲+9.66%×1.43

Feb 26 '26±12.3%▲+13.89%×1.13

Q3 FY25±11.1%▼−9.75%×0.88

IART

1 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 21 '26—▼−11.18%—

Q3 FY26—▼−21.19%—

= impliedENOV realized, solidIART realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedspan: ENOV 273d · IART 169dSource: market data

Q2 FY26

±10.9%

▼−16.55%

×1.52

May 5 '26±27.0%▲+24.13%×0.89

ENOVEnovis Corp

20.64▲+3.67%· post 20.64· delayed

Mkt cap$1.1BRevenue$583MQ2 FY26Revenue$2.2BFY25

IARTIntegra Lifesciences Holdings Corp

13.63▲+6.93%· post 13.63· delayed

After hoursNov 2 '26delayed

Mkt cap$992.0MRevenue$411MQ3 FY26Revenue$1.6BFY25

Compare

After hoursNov 2 '26delayed

ENOVEnovis Corp

IARTIntegra Lifesciences Holdings Corp

20.64▲+3.67%post 20.64delayed

Price

13.63▲+6.93%post 13.63delayed

$1.1B

Mkt cap

$992.0M

Q2 FY26$583M

Revenue

$411MQ3 FY26

FY25$2.2B

Revenue

$1.6BFY25

ENOV20.64▲+3.67%vsIART13.63▲+6.93%After hoursNov 2 '26delayed